Home » Authors » Karen Young

Articles by Karen Young

Deltagen Enters Financing Agreements For Up To $25M

July 2, 2002

Acorda Starts Phase III Trials Of Fampridine For Spasticity

July 2, 2002

Acorda Starts Phase III Trials Of Fampridine For Spasticity

July 2, 2002

Deltagen Enters Financing Agreements For Up To $25M

July 2, 2002

Exact Sciences, LabCorp Enter Molecular Diagnostics Alliance

June 28, 2002

Exact Sciences, LabCorp Enter Molecular Diagnostics Alliance

June 28, 2002

Scynexis, Merck To Collaborate On Anti-Infective Compounds

June 27, 2002

Scynexis, Merck To Collaborate On Anti-Infective Compounds

June 27, 2002

Odyssey Raises $15M In Series B To Fund Work In Drug Discovery

June 26, 2002

Odyssey Raises $15M In Series B To Fund Work In Drug Discovery

June 26, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 9, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
GLP-1 receptor agonists continue their global victory tour
BioWorld
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.